| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.091 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |